KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Current Taxes (2016 - 2025)

Eli Lilly's Current Taxes history spans 17 years, with the latest figure at $9.4 billion for Q3 2025.

  • For Q3 2025, Current Taxes changed N/A year-over-year to $9.4 billion; the TTM value through Sep 2025 reached $9.4 billion, changed N/A, while the annual FY2024 figure was $1.1 billion, N/A changed from the prior year.
  • Current Taxes reached $9.4 billion in Q3 2025 per LLY's latest filing, up from $7.0 billion in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $9.4 billion in Q3 2025 to a low of $126.6 million in Q2 2022.
  • Average Current Taxes over 5 years is $2.1 billion, with a median of $791.6 million recorded in 2021.
  • Peak YoY movement for Current Taxes: tumbled 82.66% in 2021, then surged 874.57% in 2023.
  • A 5-year view of Current Taxes shows it stood at $126.9 million in 2021, then skyrocketed by 274.39% to $475.1 million in 2022, then soared by 316.23% to $2.0 billion in 2023, then tumbled by 43.54% to $1.1 billion in 2024, then surged by 745.97% to $9.4 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Current Taxes are $9.4 billion (Q3 2025), $7.0 billion (Q2 2025), and $6.2 billion (Q1 2025).